Filing Details
- Accession Number:
- 0001209191-21-002828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-08 19:11:44
- Reporting Period:
- 2021-01-08
- Accepted Time:
- 2021-01-08 19:11:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1681682 | Endra Life Sciences Inc. | NDRA | Electromedical & Electrotherapeutic Apparatus (3845) | 260579295 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1744025 | Bertrand Renaud Maloberti | C/O Endra Life Sciences Inc. 3600 Green Court, Suite 350 Ann Arbor MI 48105 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-01-08 | 8,731 | $0.94 | 21,580 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares sold pursuant to a Rule 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.